A new T cell-redirecting strategy for the treatment of relapse/refractory T cell acute lymphoblastic leukemia
Por:
Tirado, N, Trincado, JL, Bataller, A, Petazzi, P, Bueno, C, Sanchez-Martinez, D and Menendez, P
Publicada:
1 may 2022
Resumen:
Filiaciones:
:
Josep Carreras Leukaemia Res Inst IJC, Barcelona, Spain
:
Josep Carreras Leukaemia Res Inst IJC, Barcelona, Spain
Bataller, A:
Hosp Clin Barcelona, August Pi i Sunyer Biomed Res Inst IDIBAPS, Hematol Dept, Barcelona, Spain
:
Josep Carreras Leukaemia Res Inst IJC, Barcelona, Spain
:
Josep Carreras Leukaemia Res Inst IJC, Barcelona, Spain
:
Josep Carreras Leukaemia Res Inst IJC, Barcelona, Spain
:
Josep Carreras Leukaemia Res Inst IJC, Barcelona, Spain
|